TCTR20190123002尚未招募1 期
Combined Cognitive Program
Research Management and Development Division, Office of the President, Mahidol University0 个研究点目标入组 20 人开始时间: 2019年1月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 59 Years（—）
- 性别
- All
入选标准
- •1. In-patients diagnosed with schizophrenia (Schizophrenia) adult male or female aged 18 to 59 years
- •2. Read and write Thai language
- •3. the assessment with the Mini-Mental State Examination (Thai Version or MMSE-Thai-2002) scoring ≤ 17 points for the sample. Elementary education and score ≤ 22 points for those who have higher education than elementary school.
- •4. No Psychotic symptoms
- •5. No visual impairment or hearing impairment to practice.
- •6. No communication impairment.
- •7. Willingness and willingness to participate in research.
- •8. There are no other neurological disorders such as stroke, epilepsy.
排除标准
- •1. Participants in both groups received rehabilitation therapy. Get medicines that affect thinking skills such as Donepezil
- •2. Psychotic symptoms
研究者
相似试验
已完成
3 期
A Clinical Study to Evaluate the Efficacy and Safety of PLENMOXI (Moxifloxacin Intravenous Infusion 0.4% w/v) in the Treatment of Bacterial Infections.â??CTRI/2017/11/010388OSOURCE PHARMA LTD50
已完成
不适用
A Randomized, Double-blind, Double-dummy, Active Controlled Study of Canakinumab (ACZ885) on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective-M10M10PER-149-09OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
Clinical study to evaluate the efficacy and safety of heating and cooling combination therapeutic device in chronic low back paiDiseases of the musculo-skeletal system and connective tissueKCT0001399Dongguk University Ilsan Oriental Hospital30
已完成
不适用
A prospective,randomized,single-blind,comparative study of Inslow,palatinose-based liquid formula and Meibalance,standard balanced liquid formula,using viscera fat accumulation as a primary endpoint in adults patients with confirmed diagnosis of obesity and impaired glucose tolerance.Obesity and impaired glucose toleranceJPRN-UMIN000001301Meiji Dairies Corporation50
进行中（未招募）
不适用
A randomized, double-blind, double-dummy, active controlled study of ACZ885 (canakinumab) on the treatment and prevention of gout flares in patients with frequent flares, for whom NSAIDs and/or colchicine are contraindicated, not tolerated or ineffectiveEUCTR2010-024172-26-PLovartis Pharma Services AG220